Skip Navigation
Department of Health and Human Services www.hhs.gov
 
 

Topic Suggestion Description

View Project Status

View Topic Suggestion Disposition (PDF) 1.2 MB

Date submitted: March 11, 2013

Briefly describe a specific question, or set of related questions, about a health care test or treatment that this program should consider.
Comparative effectiveness for the treatment of major depressive disorder (MDD)
Key questions:
1. For the treatment of MDD, what is the comparative effectiveness of SSRIs, placebo, psychotherapy, exercise, and alternative therapies?
2. For the treatment of MDD, what is the effectiveness of SSRIs in combination with psychotherapy, exercise, and alternative therapies?
3. What are the harms and benefits of non-pharmacologic therapies for the treatment of MDD?
4. Are there patient subgroups (e.g. by age, sex, race/ethnicity) who are more or less likely to benefit from these different treatment options?
Does your question include a comparison of different health care approaches? (If no, your topic will still be considered.)
yes
If yes, explain the specific technologies, devices, drugs, or interventions you would like to see compared:
What patients or group(s) of patients does your question apply to? (Please include specific details such as age range, gender, coexisting diagnoses, and indications for therapy.)
Are there subgroups of patients that your question might apply to? (For example, an ethnic group, stage or severity of a disease.)
Describe the health-related benefits you are interested in. (For example, improvements in patient symptoms or problems from treatment or diagnosis.)
Describe any health-related risks, side effects, or harms that you are concerned about.

Appropriateness for EHC Program

Does your question include a health care drug, intervention, device, or technology available (or likely to be available) in the U.S.?
yes
Which priority area(s) and population(s) does this topic apply to? (check all that apply)
EHC Priority Conditions (updated in 2008)
  • Depression and other mental health disorders
AHRQ Priority Populations
Federal Health Care Program

Importance

Describe why this topic is important.
What specifically motivated you to ask this question? (For example, you are developing a clinical guideline, working with a policy with large uncertainty about the appropriate approach, costly intervention, new research you have read, items in the media you may have seen, a clinical practice dilemma you know of, etc.)
Does your question represent uncertainty for clinicians and/or policy-makers? (For example, variations in clinical care, controversy in what constitutes appropriate clinical care, or a policy decision.)
yes
If yes, please explain:

Potential Impact

How will an answer to your research question be used or help inform decisions for you or your group?
Describe the timeframe in which an answer to your question is needed.
Describe any health disparities, inequities, or impact on vulnerable populations your question applies to.

Nominator Information

Other Information About You: (optional)
Please choose a description that best describes your role or perspective: (you may select more than one category if appropriate)
  • Professional Society
Are you making a suggestion as an individual or on behalf of an organization?
Organization
Please tell us how you heard about the Effective Health Care Program